Table 2.

Baseline and follow-up clinical characteristics

	Baseline	Follow-up
Number of patients	3171	2259
Mean follow-up period (month)		42.8 ± 15.8
Body mass index (kg/m2)	25.1 ± 4.2	25.2 ± 4.3
Blood pressure (mmHg)
Systolic	133.2 ± 16.9	131.7 ± 16.1
Diastolic	74.7 ± 12.1	73.1 ± 11.5
Serum creatinine (mg/dL)	0.77 ± 0.51	0.82 ± 0.36
Estimated glomerular filtration rate (ml/min/1.73 m2)	76.5 ± 22.7	75.7 ± 112.1
Low-density lipoprotein cholesterol (mg/dL)	112.8 ± 30.1	104.2 ± 29.6
Non-high-density lipoprotein cholesterol (mg/dL)	137.9 ± 35.9	128.8 ± 57.7
High-density lipoprotein cholesterol (mg/dL)	55.5 ± 15.1	54.6 ± 16.1
Triglycerides (mg/dl)	155.7 ± 128.3	139.5 ± 85.9
Blood glucose (mg/dl)	174.3 ± 64	152.7 ± 52.6
Hemoglobin A1c (%)	7.8 ± 1.2	7.2 ± 1.09